Showing results 81 to 100 of 174
< previous
next >
| Issue Date | Title | Author(s) |
| Mar-2011 | Imatinib induces autophagy through BECLIN-1 and ATG5 genes in chronic myeloid leukemia cells | Can, Geylani; Ekiz, Hüseyin Atakan ; Baran, Yusuf |
| 2009 | Imatinib induces autophagy through increasing the expression levels of Beclin-1 and ATG-5 genes in both parental sensitive and imatinib-resistant K562 cells | Baran, Yusuf ; Can, Geylani; Ekiz, Hüseyin Atakan ; Genç, S. G. |
| 6-Dec-2011 | Imatinib-induced apoptosis: A possible link to topoisomerase enzyme inhibition | Baran, Yusuf ; Zencir, Sevil; Çakır, Zeynep; Öztürk, Esra; Topçu, Zeki |
| 2013 | Immunologically detection of BCR/ABL fusion protein with flow cytometry in K562 chronic myeloid leukemia cells and comparison with RT-PCR results | Kozanoğlu, İlknur; Aygün, B.; Boğa, I.; Cansun, C.; Üstündağ, N.; Baran, Yusuf ; Özdoğu, Hakan |
| 2011 | The importance of protein profiling in the diagnosis and treatment of hematologic malignancies | Şanlı Mohamed, Gülşah ; Turan, Taylan; Ekiz, Hüseyin Atakan ; Baran, Yusuf |
| 2010 | Increasing chemosensitivity of chronic myeloid leukemia cells to dasatinib by targeting bioactive sphingolipids | Gencer, Emel Başak |
| 2009 | Increasing de novo synthesis of ceramides increased nilotinib induced apoptosis in human MEG-01 chronic megacaryoblastic cells | Baran, Yusuf ; Gençer, Emel Başak; Ural, Ali Uğur; Avcu, Ferit |
| 2009 | Increasing intracellular generation or accumulation of ceramides increased cytotoxic effects of resveratrol in human k562 chronic myeloid leukemia cells | Kartal Yandım, Melis; Saydam, Güray; Şahin, Fahri; Baran, Yusuf |
| 2014 | Inhibition of jumonji C domain containing histone demethylases in acute myeloid leukemia | Hastar, N.; Koca, D.; Baran, Yusuf |
| Jan-2017 | Intraperitoneal mesenchymal stem cell administration ameliorates allergic rhinitis in the murine model | Işık, Sakine; Karaman, Meral; Adan, Aysun ; Kıray, Müge; Bağrıyanık, Hüsnü Alper; Çağlayan Sözmen, Şule; Kozanoğlu, İlknur; Karaman, Özkan; Baran, Yusuf ; Uzuner, Nevin |
| Jul-2022 | Investigating the potential therapeutic role of targeting STAT3 for overcoming drug resistance by regulating energy metabolism in chronic myeloid leukemia cells | Tezcanlı Kaymaz, Burçin; Günel, Nur Selvi; Söğütlü, Fatma; Özateş Ay, Neslihan Pınar; Baran, Yusuf ; Gündüz, Cumhur; Biray Avcı, Çığır |
| 2014 | Investigation of effects of fisetin, vitexin and hesperetin on chronic myeloid leukemia cells | Adan Gökbulut, Aysun ; Baran, Yusuf |
| 2019 | Investigation of potential anticarcinogenic effects of corilagin in lung cancer cells | Rencüzoğulları, Çağla; Çinçin, Zeynep Birsu; İplik, Elif Sinem; Baran, Yusuf ; Çakmakoğlu, Bedia |
| 2009 | The involvement of ceramide metabolizing genes and their products in docetaxel induced apoptosis in human prostate cancer cells | Başsoy, Esen Yonca |
| 2014 | JAK/STAT Signalling pathway genes in the regulation of tyrosine kinase inhibitors induced and clinical process in chronic myeloid leukemia patients | Kiraz, Yağmur ; Kartal Yandım, Melis; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, I.; Özcan, Mehmet Ali; Saydam, Göksel; Şahin, Fahri; Avcu, Ferit; Ural, Ali Uğur; Ünal, Ali; Baran, Yusuf |
| 2019 | La médecine de précision en oncologie: challenges, enjeux et nouveaux paradigmes | Cox, Stephanie; Rousseau-Tsangaris, Marina; Abou-Zeid, Nancy; Dalle, Stephane; Leurent, Pierre; Cutivet, Arnaud; Baran, Yusuf |
| Aug-2012 | Macromolecular changes in nilotinib resistant k562 cells; An in vitro study by fourier transform infrared spectroscopy | Ceylan, Çağatay ; Camgöz, Aylin; Baran, Yusuf |
| Jul-2016 | Major apoptotic mechanisms and genes involved in apoptosis | Kiraz, Yağmur ; Adan, Aysun ; Kartal Yandım, Melis; Baran, Yusuf |
| 2007 | Mechanisms of cellular resistance to imatinib in human chronic myeloid leukemia cells | Baran, Yusuf ; Ural, Ali Uğur; Gündüz, Ufuk |
| 2010 | The mechanisms responsible for Nilotinib resistance in human chronic myeloid leukemia cells | Camgöz, Aylin |
